CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 240 enrolled
Drug / intervention
suprapubic catheterization +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02922647
NCT02922647N/ACompleted
CompareCT.gov

Suprapubic Versus Transurethral Catheterization After Rectal Resection With Low Anastomosis for Cancer in Males

University Hospital, Grenoble·interventional·Posted Oct 4, 2016·Updated Jul 21, 2022

In Brief

A clinical study evaluating suprapubic catheterization and transurethral catheterization for Infection and Cancer. Completed, enrolled 240 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the urinary tract infection rate on the four postoperative day between the 2 groups of patients who have undergone total mesorectal excision for cancer and low anastomosis, with either suprapubic or transurethral catheterization.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfection, Cancer
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 4, 2016
Enrollment StartOct 14, 2016
Primary CompletionMay 18, 2020
Study CompletionApr 16, 2021
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 9.7 years ago

Interventions

suprapubic catheterizationdevice

Experimental Arm: Suprapubic catheterization after rectal resection with low anastomosis for cancer in males

transurethral catheterizationdevice

Active comparator: Transurethral catheterization after rectal resection with low anastomosis for cancer in males